- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
32 result(s) found for: Cannulation.
Displaying page 1 of 2.
| EudraCT Number: 2015-003915-39 | Sponsor Protocol Number: 54811 | Start Date*: 2016-03-07 |
| Sponsor Name: | ||
| Full Title: A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults. | ||
| Medical condition: The enrolled subjects will get an intravenous cannulation in both elbows. The subject will get before xylocaine spray is placed, the intervention-arm, one intravenous cannulation in one of the elbo... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004993-25 | Sponsor Protocol Number: LIDPR25VER | Start Date*: 2013-01-10 |
| Sponsor Name:Verisfield (UK) Ltd | ||
| Full Title: A multicenter, randomized, patient-blind, investigator-blind, placebo-controlled, crossover study of Lidocaine + Prilocaine/Verisfield (2.5+2.5)% w/w cream and EMLA/AstraZeneca cream, in patients u... | ||
| Medical condition: Pain related to the cannulation of arteriovenous fistula cannulation in haemodialysis patients. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003275-22 | Sponsor Protocol Number: NEODEX1 | Start Date*: 2016-12-14 |
| Sponsor Name:Uppsala County Council | ||
| Full Title: Evaluation of the analgesic and sedative effects of dexmedetomidine for neonatal peripheral vein cannulation | ||
| Medical condition: Pain on i v cannulation | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006652-22 | Sponsor Protocol Number: AN08/8751 | Start Date*: 2009-06-03 |
| Sponsor Name:Leeds Teaching Hospital NHS Trust | ||
| Full Title: A multicentre, randomised, double blind, evaluative comparison trial of Rapydan® patch and Ametop® gel for topical anaesthesia during venous cannulation in adults admitted to hospital for day-case ... | ||
| Medical condition: ASA 1 and 2 patients admitted for Day case surgery- assessment of cannulation pain after topical anaesthetic applications. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-014868-19 | Sponsor Protocol Number: AKTN06.01 | Start Date*: 2011-08-19 | ||||||||||||||||
| Sponsor Name:Australian Kidney Trials Network, University of Queensland | ||||||||||||||||||
| Full Title: A randomised, double-blind, placebo-controlled, factorial-design trial to assess the effect of aspirin & fish oil in the prevention of early thrombosis in arterio-venous fistulae in patients with S... | ||||||||||||||||||
| Medical condition: Prevention of early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2017-001297-41 | Sponsor Protocol Number: OY072017 | Start Date*: 2018-02-13 |
| Sponsor Name:Oulu university hospital | ||
| Full Title: Intranasal dexmedetomidine sedation and analgesia during minor procedures in the pediatric emergency room : Randomized double-blinded clinical trial | ||
| Medical condition: Patients of the pediatric emergency room at Oulu University Hospital with any medical condition requiring a minor painful procedure such as i.v. cannulation or lumbar puncture are asked to join our... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: FI (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005473-20 | Sponsor Protocol Number: V121102015 | Start Date*: 2016-11-23 |
| Sponsor Name:UZ Leuven | ||
| Full Title: Pilot study on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion. | ||
| Medical condition: Patients with central retinal vein occlusion (CRVO) | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002308-40 | Sponsor Protocol Number: IN Morphine II | Start Date*: 2005-08-19 |
| Sponsor Name:University of Plymouth | ||
| Full Title: Evaluation of Intranasal (IN) Morphine Sulphate as a Paramedic Administered Analgesic for Children in the Pre-Hospital Environment | ||
| Medical condition: This research hopes to bridge the gap between in-hospital diamorphine and pre-hospital IV morphine by developing IN morphine for administration to children between 3 and 14 years old. This will all... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-000510-37 | Sponsor Protocol Number: GTN-1 290107 | Start Date*: 2008-04-25 |
| Sponsor Name:Nottingham Univeristy Hospitals NHS Trust | ||
| Full Title: The effect of transdermal GTN on arterial size and procedure outcomes in transradial coronary angiography - pilot study. | ||
| Medical condition: The trial is to investigate whether applying a transdermal GTN patch over the radial artery reduces spasm of the artery during coronary angiography. This is a pilot study | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003991-27 | Sponsor Protocol Number: D1690C00047 | Start Date*: 2017-12-27 |
| Sponsor Name:AstraZeneca AB | ||
| Full Title: MAAST: A Double-blind, Randomized, Phase IV, Mechanistic, Placebo-controlled, Cross-over, Single-center Study to Evaluate the Effects of 5 Weeks Dapagliflozin Treatment on Insulin Sensitivity in Sk... | ||
| Medical condition: Study to investigate mitochondrial function and insulin sensitivity in skeletal muscle in subjects with T2DM. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-014892-31 | Sponsor Protocol Number: MAIVECMOPAIN | Start Date*: 2009-11-10 |
| Sponsor Name:ErasmusMC - Sophia | ||
| Full Title: Morphine intravenous vs. Paracetamol intravenous in children on ECMO | ||
| Medical condition: Patients treated with Extra Corporal Membrane Oxygenation (ECMO) receive morphine as standardised analgesic drug. Morphine is associated with several side effects. In these patients a non-opioid dr... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003637-26 | Sponsor Protocol Number: D5881C00007 | Start Date*: 2015-02-27 |
| Sponsor Name:AstraZenenca AB | ||
| Full Title: A double-blind randomized placebo-controlled, parallel-group 12 week study to investigate the effects of Epanova® compared to placebo and compared to Fenofibrate on liver Fat content in hypertrig... | ||
| Medical condition: Patients with overweight and high serum triglyceride levels who have Non-alcoholic fatty liver disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003638-26 | Sponsor Protocol Number: D5883C00004 | Start Date*: 2014-12-03 |
| Sponsor Name:AstraZeneca AB | ||
| Full Title: A double-blind randomized placebo-controlled, parallel-group 12 week study to investigate the effects of Epanova® and dapagliFlozin on liver Fat contEnt in type 2 diabetiC patienTs; | ||
| Medical condition: Patients with type 2-diabetes who have Non-alcoholic fatty liver disease (NAFLD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005377-36 | Sponsor Protocol Number: D1690C00025 | Start Date*: 2015-02-26 |
| Sponsor Name:AstraZeneca AB, R&D Mölndal | ||
| Full Title: An 8-week, single centre, randomized, parallel-group, double-blind, placebo controlled phase IV study to evaluate Dapagliflozin 10 mg once daily effects on insulin resistance in subjects with type ... | ||
| Medical condition: type 2 diabetes mellitus. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-003176-13 | Sponsor Protocol Number: 67133 | Start Date*: 2019-02-18 |
| Sponsor Name:Maastricht University | ||
| Full Title: Lowering Branched-Chain Amino Acids as a New Strategy to Treat Diabetes | ||
| Medical condition: type 2 diabetes | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-001697-58 | Sponsor Protocol Number: 2128/2021 | Start Date*: 2022-12-20 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomi... | ||
| Medical condition: Intraoperative extra-corporeal membrane oxygenation during lung transplantation for end-stage lung disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003278-15 | Sponsor Protocol Number: AGO/2017/005 | Start Date*: 2017-12-14 |
| Sponsor Name:Ghent University Hospital | ||
| Full Title: Hyperalgesia, Persistent Pain, and Fentanyl Dosing in On-Pump Coronary Artery Bypass Grafting | ||
| Medical condition: Secondary wound hyperalgesia Persistent Pain | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001259-29 | Sponsor Protocol Number: UoL001306 | Start Date*: 2019-03-12 | |||||||||||
| Sponsor Name:University of LIverpool | |||||||||||||
| Full Title: A PHASE 1B/2A STUDY TO ASSESS THE TOLERABILITY AND ADVERSE EFFECT PROFILE OF CYSTEAMINE (CYSTAGON) IN ADULTS AND CHILDREN WITH HOMOZYGOUS ΔF508 CYSTIC FIBROSIS, IN PATIENTS TAKING EPIGALLOCATECHIN-... | |||||||||||||
| Medical condition: DeltaF508 Homozygous Cystic Fibrosis | |||||||||||||
|
|||||||||||||
| Population Age: Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-003570-26 | Sponsor Protocol Number: CLN-PRO-V011 | Start Date*: 2019-09-07 | ||||||||||||||||
| Sponsor Name:Humacyte, Inc. | ||||||||||||||||||
| Full Title: A Phase 2 Assessment of Humacyte’s Human Acellular Vessel in Patients Needing Vascular Access for Dialysis | ||||||||||||||||||
| Medical condition: End-stage renal disease (ESRD) requiring placement of an arteriovenous (AV) graft in the arm (upper- or forearm) for dialysis access. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: PL (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2019-001143-43 | Sponsor Protocol Number: EU-KKO-LNG-02-2018 | Start Date*: 2019-10-07 | ||||||||||||||||
| Sponsor Name:Gedeon Richter Plc. | ||||||||||||||||||
| Full Title: An Open-label, Multi-center, Pharmacokinetic/Pharmacodynamic Study to Evaluate the Effect of a Single Dose of Levonorgestrel 1.5 mg Tablet on Ovulation Inhibition during Mid-follicular Phase in Und... | ||||||||||||||||||
| Medical condition: Ovulation | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
